documents: FDA-2026-N-2590-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-2590-0001 FDA FDA-2026-N-2590 Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests Proposed Rule Request for Comment 2026-03-30T04:00:00Z 2026 3 2026-03-30T04:00:00Z 2026-05-30T03:59:59Z 2026-05-13T09:00:24Z 2026-06064 1 0 09000064b92437b6

Links from other tables